Relevance of EORTC Criteria for the Diagnosis of Invasive Aspergillosis in HIV-Infected Patients, and Survival Trends Over a 20-Year Period in France
The DOI matches its Crossref record, with a small difference in title or year; 13 of the 13 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Before the advent of combination antiretroviral therapy (cART), roughly 50% of cases of invasive aspergillosis (IA) associated with human immunodeficiency virus (HIV) infection involved individuals without classical predisposing host factors, and the median survival time was <4 months after diagnosis. We examined if the situation evolved over time using the revised European Organisation for Research and Treatment of Cancer/National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC) definition and analyzed survival trends after diagnosis over 20 years. METHODS: A data review committee evaluated 342 medical records that mentioned IA in the French Hospital Database on HIV. Validated cases were classified as fulfilling the EORTC criteria or otherwise as "HIV-related IA." Three periods were analyzed: pre-cART (before 1996), cART era prevoriconazole (1996-2001), and 2002-2011. RESULTS: Among 242 validated cases of IA, 124 (51%) fulfilled the EORTC criteria (EORTC-IA) and 118 (49%) were classified as "HIV-related," with similarly low CD4 cell counts in both groups. The proportion of EORTC-IA cases remained stable across the 3 periods (50%, 48%, and 54%, respectively). The 3-month survival rate improved after the advent of cART (38% vs 69%), with no difference between EORTC-IA and HIV-related IA (hazard ratio [HR], 1.2 95% confidence interval [CI] {0.7-1.8}). Voriconazole exposure decreased mortality in 2002-2011 (HR, 0.1 95% CI [0.01-0.8]). CONCLUSIONS: In the cART era, EORTC criteria, developed for use in hematology/oncology, still applied to only half the cases diagnosed among HIV-infected patients. A rapid diagnosis of IA is paramount to improve survival. For patients who do not fulfill the EORTC definition, we suggest that the addition of "HIV infected with a CD4 count <100 cells/µL" to the EORTC host criteria be validated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In no country were estimates of IA complicating AIDS included, although found in ~4% of autopsies in developed countries [118], in the era prior to, A.R.T.; but still present [119].”
From Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision (2017) · cites this paper as [119]
In the citing paper
“However, a large proportion of IPA cases still are not detected by existing criteria, especially in nonneutropenic patients who possess atypical clinical and radiographic features of infection (95–97).”
From Aspergillus fumigatus and Aspergillosis in 2019 (2019) · cites this paper as [96]
Citations
Cites
De Pauw, B., Walsh, T. J., Donnelly, J. P., Stevens, D. A., Edwards, J. E., Calandra, T., Pappas, P. G., Maertens, J., Lortholary, O., Kauffman, C. A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/588660 · Cited by 4,917 · cited 3×
“Each case was checked for the EORTC criteria [7].”
BackgroundMethodSelf-citationVoriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
Herbrecht, R., Denning, D. W., Patterson, T. F., Bennett, J. E., Greene, R. E., Oestmann, J.-W., Kern, W. V., Marr, K. A., Ribaud, P., Lortholary, O., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020191 · Cited by 3,304
Self-citationUpton, A., Kirby, K. A., Carpenter, P., Boeckh, M., & Marr, K. A. (2007) · Clinical Infectious Diseases · doi:10.1086/510592 · Cited by 514
Pulmonary Aspergillosis in the Acquired Immunodeficiency Syndrome
Denning, D. W., Follansbee, S. E., Scolaro, M., Norris, S., Edelstein, H., & Stevens, D. A. (1991) · New England Journal of Medicine · doi:10.1056/nejm199103073241003 · Cited by 503
Invasive aspergillosis in patients with acquired immunodeficiency syndrome: Report of 33 cases
Lortholary, O., Meyohas, M.-C., Dupont, B., Cadranel, J., Salmon-Ceron, D., Peyramond, D., & Simonin, D. (1993) · The American Journal of Medicine · doi:10.1016/0002-9343(93)90258-q · Cited by 199
Self-citationInvasive Aspergillosis in Patients with AIDS
Khoo, S. H., & Denning, D. W. (1994) · Clinical Infectious Diseases · doi:10.1093/clinids/19.supplement_1.s41 · Cited by 166
Invasive Aspergillosis in Patients with AIDS
Minamoto, G. Y., Barlam, T. F., & Els, N. J. V. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.1.66 · Cited by 148
Pulmonary Aspergillosis in Patients With AIDS
Miller, W. T., Sais, G. J., Frank, I., Gefter, W. B., Aronchick, J. M., & Miller, W. T. (1994) · CHEST Journal · doi:10.1378/chest.105.1.37 · Cited by 144
Depressed Neutrophil Superoxide Production in Human Immunodeficiency Virus Infection
Pitrak, D. L., Bak, P. M., DeMarais, P., Novak, R. M., & Andersen, B. R. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.6.1406 · Cited by 85
Cohort Profile: French hospital database on HIV (FHDH-ANRS CO4)
Mary‐Krause, M., Grabar, S., Lièvre, L., Abgrall, S., Billaud, E., Boué, F., Boyer, L., Cabie, A., Cotte, L., de Truchis, P., et al. (2014) · International Journal of Epidemiology · doi:10.1093/ije/dyu002 · Cited by 82
Self-citation
Cited by
Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision
Bongomin, F., Gago, S., Oladele, R., & Denning, D. (2017) · Journal of Fungi · doi:10.3390/jof3040057 · Cited by 2,953
Ullmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.002 · Cited by 1,556
Self-citationAspergillus fumigatus and Aspergillosis in 2019
Latgé, J.-P., & Chamilos, G. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00140-18 · Cited by 1,400
The Changing Epidemiology of Invasive Fungal Infections
Enoch, D. A., Yang, H., Aliyu, S. H., & Micallef, C. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-6515-1_2 · Cited by 370
Hosseini-Moghaddam, S. M., Ouédraogo, A. M., Naylor, K. L., Bota, S. E., Husain, S., Nash, D. M., & Paterson, J. M. (2020) · Transplant Infectious Disease · doi:10.1111/tid.13250 · Cited by 91
Francesco, M. A. D. (2023) · Pathogens · doi:10.3390/pathogens12111305 · Cited by 81
Boroujeni, Z. B., Shamsaei, S., Yarahmadi, M., Getso, M. I., Khorashad, A. S., Haghighi, L., Raissi, V., Zareei, M., Mohammadzade, A. S., Moqarabzadeh, V., et al. (2020) · Microbial Pathogenesis · doi:10.1016/j.micpath.2020.104616 · Cited by 73
Why are so many cases of invasive aspergillosis missed?
Danion, F., Rouzaud, C., Dureault, A., Poirée, S., Bougnoux, M., Alanio, A., Lanternier, F., & Lortholary, O. (2018) · Medical Mycology · doi:10.1093/mmy/myy081 · Cited by 55
Self-citationChallenges in microbiological diagnosis of invasive Aspergillus infections
Alanio, A., & Bretagne, S. (2017) · F1000Research · doi:10.12688/f1000research.10216.1 · Cited by 43
Quantifying Deaths from Aspergillosis in HIV Positive People
Denning, D. W., & Morgan, E. F. (2022) · Journal of Fungi · doi:10.3390/jof8111131 · Cited by 38
Smoking as a Risk Factor of Invasive Fungal Disease: Systematic Review and Meta-Analysis
Pourbaix, A., Rapnouil, B. L., Guéry, R., Lanternier, F., Lortholary, O., & Cohen, J. F. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa001 · Cited by 29
Self-citationEstimates of serious fungal infection burden in Côte d’Ivoire and country health profile
Koffi, D., Bonouman, I. V., Touré, A., Kouadjo, F. K., N’gou, M. E. R. E., Sylla, K., Dosso, M. B., & Denning, D. W. (2020) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2020.101086 · Cited by 26
Aspergillus spp. invasive external otitis: favourable outcome with a medical approach
Marchionni, E., Parize, P., Lefèvre‐Utile, A., Vironneau, P., Bougnoux, M., Poirée, S., Coignard-Biehler, H., DeWolf, S., Amazzough, K., Barchiesi, F., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.12.027 · Cited by 22
Self-citationNeglected mycobiome in HIV infection: Alterations, common fungal diseases and antifungal immunity
Li, S., Yang, X., Moog, C., Wu, H., Su, B., & Zhang, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1015775 · Cited by 17
Prognosis of Invasive Aspergillosis in Kidney Transplant Recipients: A Case-Control Study
Desbois, A. C., Poirée, S., Snanoudj, R., Bougnoux, M., Sberro‐Soussan, R., Lanternier, F., Legendre, C. M., Lortholary, O., & Scemla, A. (2016) · Transplantation Direct · doi:10.1097/txd.0000000000000584 · Cited by 16
Self-citationNoval, C., Ruiz, S., Gonçalves, D. D. S., Ferreira, M. D. S., Honorato, L., Peralta, J. M., Nimrichter, L., & Guimaraes, A. J. (2020) · Journal of Fungi · doi:10.3390/jof6040250 · Cited by 14
Dockrell, D. H., Breen, R. A. M., Collini, P., Lipman, M. C. I., & Miller, R. F. (2024) · HIV Medicine · doi:10.1111/hiv.13637 · Cited by 12
Lamoth, F., Albrich, W. C., Ragozzino, S., Bosetti, D., Delaloye, J., Khoury, C. E., Munting, A., Portillo, V., Reinhold, I., Sumer, J., et al. (2025) · Mycoses · doi:10.1111/myc.70132 · Cited by 13
Pulmonary Infections in People Living with HIV
Franquet, T., & Domingo, P. (2022) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2022.01.008 · Cited by 11
Tio, S. Y., Chen, S. C. ‐., Heath, C. H., Pradhan, A., Morris, A. J., Korman, T. M., Morrissey, C. O., Halliday, C. L., Kidd, S. E., Spelman, T., et al. (2024) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofae594 · Cited by 7
Truda, V. S. S., Falci, D. R., Porfírio, F. M. V., de Santos, D. W. D. C. L., de Oliveira, F. I., Pasqualotto, A. C., Puga, F. G., Bóllela, V. R., de Almeida, J. N., Ferreira, P. R. A., et al. (2023) · Mycoses · doi:10.1111/myc.13589 · Cited by 10
“Chronic Disseminated Aspergillosis,” a Novel Fungal Immune Reconstitution Inflammatory Syndrome
Pourbaix, A., Guéry, R., Bruneau, J., Blanc, E., Jouvion, G., Weinandt, M., Rouzaud, C., Lourenço, J., Boutboul, D., Mira, J. P., et al. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa175 · Cited by 5
Self-citationCachera, L., Adenis, A. A., Guarmit, B., Rabier, S., Couppié, P., Djossou, F., Epelboin, L., Melzani, A., Abboud, P., Blanchet, D., et al. (2021) · Journal of Fungi · doi:10.3390/jof7060421 · Cited by 7
Abdullahi, I. N., Shuwa, H. A., Emeribe, A. U., Adekola, H. A., & Dangana, A. (2018) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_46_18 · Cited by 4
Dias, C., Duarte-Ribeiro, F., Pipa, S., & Mota, M. (2018) · Case Reports in Infectious Diseases · doi:10.1155/2018/3269847 · Cited by 4
Oñate, J., Rivas-Pinedo, P., Saavedra-Trujillo, C. H., Camacho‐Moreno, G., Cuervo, S. I., Enciso-Olivera, L. J., Patiño-Escobar, B., Osorio, J. P., Berrío, I., Álvarez, C., et al. (2022) · Infectio · doi:10.22354/24223794.1064 · Cited by 2
Invasive Pulmonary Aspergillosis in Other Patient Populations
Kanj, A., Doumat, G., & LIMPER, A. H. (2024) · Springer eBooks · doi:10.1007/978-3-031-76524-7_15 · Cited by 1
Denis, B. (2016) · theses.fr (ABES) · doi:10.70675/996fe660z270ez4f9ezabd4z1483c58cba07
Self-citationFungal infections among patients with AIDS
Denis, B., Lanternier, F., & Lortholary, O. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780198755388.003.0033
Self-citationRedrado, S., Jimeno, J. P., & Buerba, E. M. G. (2023) · Zaguan (University of Zaragoza Repository)
Severe hyperkalaemia during liposomal amphotericin B treatment, independent of nephrotoxicity
Gourjault, C., Pietri, T., Carvelli, J., Ranque, S., & Cassir, N. (2026) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2026.107054
Aspergillus, Aspergillosis, Antifungal Resistance and Dispersal
Wilkinson, D. (2026) · Aerobiology · doi:10.3390/aerobiology4040022
Management of invasive fungal infections in the intensive care unit
Chean, D., Friol, A., Azoulay, É., & Maillard, A. (2026) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2026.2710718
Metadata
- Authors
- Denis, B., Guiguet, M., de Castro, N., Mechaï, F., Revest, M., Melica, G., Costagliola, D., & Lortholary, O.
- Affiliations
- Inserm (FR)
- Centre Hospitalier Universitaire de Rennes (FR)
- Centre Hospitalier Universitaire Henri-Mondor (FR)
- Sorbonne Université (FR)
- Hôpital Necker-Enfants Malades (FR)
- Corresponding author
- Denis, Blandine
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-06-29
- Volume
- 61
- Issue
- 8
- Pages
- 1273-1280
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2205816243
- Cited by
- 33
- References
- 13
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 4 · 2021: 2 · 2020: 6 · 2019: 1 · 2018: 5 · 2017: 3 · 2016: 3
- FWCI
- 2.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Funders
- Agence Nationale de Recherche sur le SIDA et les hépatites virales
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Health Sciences › Medicine › Ophthalmology › Ocular Infections and Treatments
- Keywords
- invasive aspergillosis, HIV infection, EORTC criteria, diagnostic criteria, survival trends, highly active antiretroviral therapy, voriconazole, CD4 count, opportunistic fungal infection
- MeSH terms
- Adult, Antifungal Agents, Aspergillosis, Aspergillus, Drug Therapy, Combination, Female, France, Humans, Male, Medical Records, Middle Aged, Time Factors, HIV Infections, Survival Rate, Proportional Hazards Models, CD4 Lymphocyte Count, Anti-HIV Agents, Invasive Pulmonary Aspergillosis, Voriconazole
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.